D1、D2 和 D3。 - Suppr

Suppr

超能文献

D1 and D2 and D3.

作者信息

Healy D

机构信息

Academic Unit, North Wales Hospital, Denbigh, Clwyd.

出版信息

Br J Psychiatry. 1991 Sep;159:319-24. doi: 10.1192/bjp.159.3.319.

DOI:10.1192/bjp.159.3.319

PMID:1683592

Abstract

摘要

相似文献

D1 and D2 and D3.

Br J Psychiatry. 1991 Sep;159:319-24. doi: 10.1192/bjp.159.3.319.

[The dopaminergic hypothesis revisited].

Encephale. 2006 Oct;32(5 Pt 4):S908-11; discussion S912. doi: 10.1016/s0013-7006(06)76262-5.

Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.

Br J Psychiatry Suppl. 1994 Apr(23):65-70.

Plasma homovanillic acid, plasma anti-D1 and -D2 dopamine-receptor activity, and negative symptoms in chronically mediated schizophrenia.

Biol Psychiatry. 1992 Feb 15;31(4):357-64. doi: 10.1016/0006-3223(92)90229-s.

Schizophrenia: D4 receptor elevation. What does it mean?

J Psychiatry Neurosci. 1994 May;19(3):171-6.

Dopamine receptor pharmacology.

Curr Opin Neurol Neurosurg. 1993 Aug;6(4):602-8.

[Neuroendocrinology and schizophrenia research].

Monogr Gesamtgeb Psychiatr Psychiatry Ser. 1991;64:1-96.

Update on dopamine receptors.

Ann Clin Psychiatry. 1994 Jun;6(2):79-90. doi: 10.3109/10401239409148986.

Recent developments in PET scan imaging of neuroreceptors in schizophrenia.

Isr J Psychiatry Relat Sci. 1995;32(1):22-9.

Dopamine receptors and schizophrenia.

Biochem Soc Trans. 1996 Feb;24(1):202-5.

引用本文的文献

Understanding antipsychotic "atypicality": a clinical and pharmacological moving target.

J Psychiatry Neurosci. 2003 Jul;28(4):275-84.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

D1 and D2 and D3.

Br J Psychiatry. 1991 Sep;159:319-24. doi: 10.1192/bjp.159.3.319.

[The dopaminergic hypothesis revisited].

Encephale. 2006 Oct;32(5 Pt 4):S908-11; discussion S912. doi: 10.1016/s0013-7006(06)76262-5.

Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.

Br J Psychiatry Suppl. 1994 Apr(23):65-70.

Plasma homovanillic acid, plasma anti-D1 and -D2 dopamine-receptor activity, and negative symptoms in chronically mediated schizophrenia.

Biol Psychiatry. 1992 Feb 15;31(4):357-64. doi: 10.1016/0006-3223(92)90229-s.

Schizophrenia: D4 receptor elevation. What does it mean?

J Psychiatry Neurosci. 1994 May;19(3):171-6.

Dopamine receptor pharmacology.

Curr Opin Neurol Neurosurg. 1993 Aug;6(4):602-8.

[Neuroendocrinology and schizophrenia research].

Monogr Gesamtgeb Psychiatr Psychiatry Ser. 1991;64:1-96.

Update on dopamine receptors.

Ann Clin Psychiatry. 1994 Jun;6(2):79-90. doi: 10.3109/10401239409148986.

Recent developments in PET scan imaging of neuroreceptors in schizophrenia.

Isr J Psychiatry Relat Sci. 1995;32(1):22-9.

Dopamine receptors and schizophrenia.

Biochem Soc Trans. 1996 Feb;24(1):202-5.

引用本文的文献

Understanding antipsychotic "atypicality": a clinical and pharmacological moving target.

J Psychiatry Neurosci. 2003 Jul;28(4):275-84.